Glutamine Metabolism in Cancer: Understanding the Heterogeneity

Cluntun, A. A., Lukey, M. J., Cerione, R. A., Locasale, J. W. (March 2017) Glutamine Metabolism in Cancer: Understanding the Heterogeneity. Trends Cancer, 3 (3). pp. 169-180. ISSN 2405-8033

URL: https://www.ncbi.nlm.nih.gov/pubmed/28393116
DOI: 10.1016/j.trecan.2017.01.005

Abstract

Reliance on glutamine has long been considered a hallmark of cancer cell metabolism. However, some recent studies have challenged this notion in vivo, prompting a need for further clarifications on the role of glutamine metabolism in cancer. We find that there is ample evidence of an essential role for glutamine in tumors and that a variety of factors, including tissue type, the underlying cancer genetics, the tumor microenvironment and other variables such as diet and host physiology collectively influence the role of glutamine in cancer. Thus the requirements for glutamine in cancer are overall highly heterogeneous. In this review, we discuss the implications both for basic science and for targeting glutamine metabolism in cancer therapy.

Item Type: Paper
Subjects: diseases & disorders > cancer
bioinformatics > genomics and proteomics > genetics & nucleic acid processing > epigenetics
bioinformatics > genomics and proteomics > genetics & nucleic acid processing > DNA, RNA structure, function, modification > epigenetics
organs, tissues, organelles, cell types and functions > organs types and functions > metabolism
diseases & disorders > cancer > drugs and therapies > tumor microenvironment
CSHL Authors:
Communities: CSHL labs > Lukey lab
Depositing User: Adrian Gomez
Date: March 2017
Date Deposited: 27 Jan 2020 16:26
Last Modified: 27 Jan 2020 16:26
PMCID: PMC5383348
Related URLs:
URI: https://repository.cshl.edu/id/eprint/38929

Actions (login required)

Administrator's edit/view item Administrator's edit/view item
CSHL HomeAbout CSHLResearchEducationNews & FeaturesCampus & Public EventsCareersGiving